Transcend Wealth Collective »

Prime Medicine shares owned by Transcend Wealth Collective

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Transcend Wealth Collective from 13F filings

Historical chart of Transcend Wealth Collective investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Transcend Wealth Collective consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Transcend Wealth Collective

Quarter filed Position value Share count Share price at filing
2025-12-31 $92k 27k 3.47

More positions owned by Transcend Wealth Collective

Apple Stock (AAPL)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Microsoft Corp Stock (MSFT)
Merck & Co Stock (MRK)
State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Invesco Qqq Trust Series I Etf (QQQ)
Nvidia Corporation Stock (NVDA)
Amazon Stock (AMZN)
Spdr S&p 500 Etf Trust Etf (SPY)
International Business Machs Stock (IBM)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Vanguard High Dividend Yield Index Etf Etf (VYM)
Vaneck Bdc Income Etf Etf (BIZD)
Blue Owl Capital Inc Com Cl A Stock (OWL)
Blue Owl Capital Corporation Cef (OBDC)

View all positions for Transcend Wealth Collective

Top funds holding Prime Medicine

Alphabet
BlackRock
Vanguard Group
T. Rowe Price Investment Management
ARK Investment Management
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Casdin Capital
Woodline Partners
RA Capital Management
FMR
Geode Capital Management
UBS Group
D. E. Shaw & Co

View all funds holding Prime Medicine